Skip to main content
OSCR logo

OSCR · Oscar Health, Inc. · Financials

Track OSCR — free
$30.67 -0.17 (-0.55%)
Market Cap
$9.14B
Shares
308.64M
Volume · Sep 30 5.45M Avg daily vol (3M) 5.31M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$11.7B +27.5%
FY2025 Revenue FY2019–FY2025
Net Income
-$443.15M -1842.5%
FY2025 Net Income FY2019–FY2025
Operating Margin
-3.39% -4pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$1.69 -1790%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
$1.09B +11.9%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$15.32B $11.7B $9.18BG $5.86B $3.96B $1.84B $462.8M $488.19M
$15.04B $11.47B $8.97B $5.69B $3.87B $1.83B $455.04M $468.86M
$28.27M $28.89M $32.15M $30.69M $15.28M $265.08M $166.66M $110.68M
$2.43B $2.05B $1.76B $1.43B $1.26B — — —
$28.24M $28.89M $32.15M $30.69M $15.28M $14.61M $11.29M $6.9M
$629.72M -$396.36M $57.27M -$235.62M -$589.87M -$544.48M -$402.27M -$259.39M
— -3.39% 0.62% -4.02% -14.88% -29.61% -86.92% -53.13%
$657.96M -$367.47M $89.41M -$204.92M -$574.58M -$529.88M -$390.98M -$252.49M
$15.85M $17.6M $23.73M $24.6M $22.62M $4.72M $3.51M $0
-$24.06M -$23.34M -$105K -$7.08M $2.42M -$1.2M — —
-$74K — — — -$1.27M $212K $1.24M $481K
$589.81M -$437.3M $33.43M -$267.3M -$610.08M -$570.58M -$405.78M -$259.39M
$38.88M $5.61M $7.31M $3.29M -$523K $846K $1.05M $1.79M
$550.74M -$443.15M $25.43M -$270.73M -$606.28M -$572.61M -$406.83M -$261.18M
— -3.79% 0.28% -4.62% -15.3% -31.14% -87.9% -53.5%
$190K $248K $689K $134K -$3.28M $1.18M $0 $0
— -$443.15M $25.43M -$270.73M -$606.28M -$572.61M -$414.24M -$261.18M
$528.77M -$423.29M $22.3M -$259.7M -$612.32M -$577.16M -$405.92M -$261.17M
USD/shares $1.58 -$1.69 $0.11 -$1.22 -$2.85 -$3.20 -$14.16 -$9.06
USD/shares $1.45 -$1.69 $0.10 -$1.22 -$2.85 -$3.20 -$14.16 -$9.06
shares — 262.39M 240.39M 221.66M 212.48M 178.97M 29.26M 28.81M
shares — 262.39M 265.85M 221.66M 212.48M 178.97M 29.26M 28.81M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2021: $2.99M in buybacks.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.29×
EV/EBIT
—
Peer median 17.93×
P/E (TTM)
20.41×
Peer median 22.59×

Peer medians compare against the 8 similar-size Healthcare Plans companies (of 13 listed).

Valuation over time computed as of each quarter's filing date

Key facts CIK 1568651 CUSIP 687793109 13F (30d) 11 filings 9 filers Visit website Investor relations